PMC7543135_01
Bilateral patchy ground glass opacities in bronchovascular distribution.
10.1177_2324709620947267-fig1.jpg
PMC7543135_01_10.1177_2324709620947267-fig1.jpg
fig1-2324709620947267
Computed tomography angiogram (CTA) of the chest with and without contrast revealed bilateral patchy ground glass opacities within the bronchovascular distribution (Figure 1).
PMC7543135_02
Mild ground glass opacities to upper lobe with bilateral lower lobe dense
consolidations.
10.1177_2324709620947267-fig2.jpg
PMC7543135_02_10.1177_2324709620947267-fig2.jpg
fig2-2324709620947267
CXR showed bilateral air space disease and CT of the chest without contrast showed bilateral upper lobe ground glass opacities and lower lobe dense consolidations (Figure 2).
PMC7543135_03
Bilateral ground glass patchy infiltrates with subpleural sparing and small
right pleural effusion.
10.1177_2324709620947267-fig3.jpg
PMC7543135_03_10.1177_2324709620947267-fig3.jpg
fig3-2324709620947267
Initial CXR showed bilateral infiltrates and CT chest without contrast showed bilateral patchy glass patchy opacities with subpleural sparing and small right pleural effusion (Figure 3).
PMC7543135_04
Bilateral upper lobe ground glass opacities centrally distributed.
10.1177_2324709620947267-fig4.jpg
PMC7543135_04_10.1177_2324709620947267-fig4.jpg
fig4-2324709620947267
Her respiratory status declined over the next few days and CTA of chest later showed bilateral upper lobe ground glass opacities (Figure 4).
PMC7543135_05
(a) Pretreatment:bilateral upper lobe patchy ground-glass infiltrates. (b)
Posttreatment:interval improvement of patchy bilateral upper lobe
infiltrates with small residual superior segment right lower lobe
ground-glass opacity.
10.1177_2324709620947267-fig5.jpg
PMC7543135_05_10.1177_2324709620947267-fig5.jpg
fig5-2324709620947267
CRP, and urine drug screen was positive for cannabinoids/THC (Table 1). Extensive infectious workup including sputum studies urine and serum studies were negative (Table 1). CXR showed bilateral interstitial infiltrates and CTA of the chest with and without contrast confirmed bilateral upper lobe ground glass patchy infiltrates (Figure 5(a)). A repeat CT chest with contrast 6 days after steroid initiation showed interval improvement of patchy bilateral infiltrates with a small residual superior segment of right lower lobe ground glass opacity (Figure 5(b)).
PMC7543135_06
Bilateral pleural effusions with peribronchovascular ground glass infiltrates
with septal thickening, nodular pattern.
10.1177_2324709620947267-fig6.jpg
PMC7543135_06_10.1177_2324709620947267-fig6.jpg
fig6-2324709620947267
CRP, and urine drug screen was positive for cannabinoids/THC (Table 1). Extensive infectious workup including sputum studies urine and serum studies were negative (Table 1). CTA of the chest showed bilateral diffuse ground glass opacities with septal thickening, tree in bud opacities, and bilateral pleural effusions (Figure 6).
PMC7543135_07
Diffuse bilateral ground glass opacities with crazy paving pattern with
subpleural sparing.
10.1177_2324709620947267-fig7.jpg
PMC7543135_07_10.1177_2324709620947267-fig7.jpg
fig7-2324709620947267
CXR showed bilateral patchy opacities and CTA of the chest showed diffuse ground-glass opacities with crazy paving pattern with subpleural sparing (Figure 7).